Antitrust Under Trump: Initial Policies and Actions

By Jon B. Dubrow, Michelle Lowery and Megan Ingram on March 6, 2025

Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Joint Ventures/Competitor Collaboration, Mergers & Acquisitions, Monopolization/Abuse of Dominance

The Trump administration has initiated significant changes in antitrust policy through key appointments and policy announcements. The administration announced that the Federal Trade Commission (FTC) and US Department of Justice (DOJ) will continue using the 2023 Merger Guidelines and expressed support for new Hart-Scott-Rodino (HSR) rules. Additionally, the FTC outlined its goals, which include improving the merger review process by moving more quickly, accepting settlements where warranted, and combating Big Tech censorship.

Jon B. Dubrow
Jon Dubrow is the US head of McDermott’s Antitrust Group and a strategic advisor to clients across a host of interrelated antitrust issues, including mergers and acquisitions (M&A) transactions and merger clearance, counseling, and litigation. He leads the defense of mergers, acquisitions and joint ventures before the Department of Justice, the Federal Trade Commission and other international competition authorities. Jon also regularly assists third parties whose interests are adversely affected by proposed transactions. Jon also is experienced in antitrust litigation. He provides counseling on distribution issues, contracting arrangements and a wide variety of other competition-related matters. Read Jon Dubrow's full bio.

Michelle Lowery
Michelle Lowery is the go-to litigator for West Coast state and federal antitrust and unfair competition matters and for California Attorney General antitrust and general litigation matters. She has nearly two decades of experience achieving exceptional results for clients in antitrust and unfair competition litigation and investigations, including class actions. Read Michelle Lowery's full bio.

Megan Ingram
Megan Ingram focuses her practice on assessing and mitigating antitrust risk in public and private M&A transactions. She supports US and international clients with merger review, obtaining clearance under the Hart-Scott-Rodino Act, antitrust compliance, and governmental antitrust investigations. Megan has experience across multiple industries, including software and technology, healthcare and life sciences, consumer products, aerospace and defense, and industrials. Read Megan Ingram's full bio.

Antitrust Under Trump: Initial Policies and Actions

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS